pf 5901 has been researched along with fpl 55712 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Musser, JH | 1 |
| Campbell, HF; Chan, WK; Galemmo, RA; Huang, FC; Johnson, WH; Lee, TD; Lin, CJ; Magnien, E; Tan, J; Youssefyeh, RD | 1 |
| Chakraborty, UR; Coutts, SM; Gordon, RJ; Khandwala, A; Musser, JH; Neiss, ES; Pruss, TP; Sciortino, S; Van Inwegen, R; Weinryb, I | 1 |
| Brooks, CD; Summers, JB | 1 |
| Coutts, S; Gordon, R; Jolly, S; Khandwala, A; Sonnino, P; Van Inwegen, RG | 1 |
| Jolly, SR; Travis, J; Van Inwegen, RG | 1 |
| Barnes, N; Costello, J; Evans, J; Piper, P; Zakrzewski, J | 1 |
3 review(s) available for pf 5901 and fpl 55712
| Article | Year |
|---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
Modulators of leukotriene biosynthesis and receptor activation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene | 1996 |
Studies of leukotriene antagonists and synthesis inhibitors in man.
Topics: Acetophenones; Asthma; Chromones; Epoprostenol; Humans; Hydroxyquinolines; Keto Acids; Leukotriene B4; Phenylbutyrates; Quinolines; SRS-A; Sulfones; Tetrazoles | 1988 |
4 other study(ies) available for pf 5901 and fpl 55712
| Article | Year |
|---|---|
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.
Topics: Animals; Azoles; Bronchodilator Agents; Chemical Phenomena; Chemistry; Guinea Pigs; Hydroxyquinolines; Leukotriene Antagonists; Lung; Phenyl Ethers; Quinolines; Receptors, Immunologic; Receptors, Leukotriene B4; Structure-Activity Relationship; Tetrazoles | 1990 |
Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.
Topics: Animals; Arachidonate Lipoxygenases; Hydroxyeicosatetraenoic Acids; Indicators and Reagents; Lipoxygenase Inhibitors; Lung; Neutrophils; Phenyl Ethers; Rats; SRS-A; Structure-Activity Relationship | 1987 |
REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Chromones; Coronary Circulation; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Hydroxyquinolines; Kinetics; Lung; Male; Methacholine Chloride; Methacholine Compounds; Muscle Contraction; Myocardial Contraction; Quinolines; Regional Blood Flow; SRS-A | 1987 |
Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
Topics: Acetophenones; Anaphylaxis; Animals; Arachidonate Lipoxygenases; Benzoquinones; Benzyl Compounds; Blood Pressure; Cardiomyopathies; Chromones; Coronary Circulation; Guinea Pigs; Heart; Hydroxamic Acids; Hydroxyquinolines; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Male; Myocardium; Quinolines; Quinones; SRS-A; Tetrazoles | 1989 |